Clinical Trial Update: MK0653A (Ezetimibe (+) Simvastatin) Compared to an Approved Drug (Atorvastatin) for the Treatment of High Cholesterol (0653A-051)(COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing MK0653A (ezetimibe plus simvastatin) against atorvastatin for hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• MK0653A
• atorvastatin (atorvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED